Calithera Biosciences, Inc. (CALA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -43.6 Million | -66.3 Million | -84.31 Million | -78.74 Million | -64.84 Million | 13.75 Million |
| Net Income | -39.65 Million | -115.08 Million | -90.13 Million | -89.86 Million | -54.62 Million | -27.82 Million |
| Depreciation & Amortization | 255 Thousand | 280 Thousand | 364 Thousand | 479 Thousand | 505 Thousand | 365 Thousand |
| Deferred income taxes | - | 2000.00 | -142 Thousand | -897 Thousand | - | - |
| Stock-based compensation | 4.03 Million | 10.26 Million | 8.06 Million | 6.46 Million | 7.43 Million | 5.53 Million |
| Change in working capital | -7.42 Million | -3.4 Million | -3.96 Million | 3.7 Million | -17.88 Million | 35.22 Million |
| Other non-cash items | -817 Thousand | 41.64 Million | 1.5 Million | 1.36 Million | -272 Thousand | 455 Thousand |
| Investing Cash Flow | -133 Thousand | 7.85 Million | 88.96 Million | -10.78 Million | 52.79 Million | -98.82 Million |
| Investments in PPE | -133 Thousand | -147 Thousand | -61 Thousand | -7000.00 | -214 Thousand | -1.22 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -57.05 Million | -153.22 Million | -76.1 Million | -194.65 Million |
| Sales/Maturities of investments | - | 8 Million | 146.08 Million | 142.45 Million | 129.12 Million | 97.44 Million |
| Other Investing Activities | - | - | - | - | - | -394 Thousand |
| Financing Cash Flow | 9.65 Million | 10.66 Million | 42.06 Million | 98.9 Million | 14.62 Million | 122.94 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 7.91 Million |
| Common Stock Issuance | 9.63 Million | 10.66 Million | 40.86 Million | 97.68 Million | 13.7 Million | 121.61 Million |
| Other Financing Activities | 16 Thousand | 4000.00 | 1.2 Million | 1.22 Million | 921 Thousand | -6.58 Million |
| Accounts receivables | - | 1.54 Million | -1.05 Million | 1.51 Million | -855 Thousand | -1.14 Million |
| Accounts payables | -2.91 Million | 1.65 Million | -58 Thousand | 816 Thousand | 175 Thousand | 674 Thousand |
| Inventory | - | - | - | 1.08 Million | 5.01 Million | 3.98 Million |
| Other working capital | -4.5 Million | -5.06 Million | -3.9 Million | 289 Thousand | -22.21 Million | 31.7 Million |
| Cash at beginning of period | 59.8 Million | 107.58 Million | 60.87 Million | 51.49 Million | 48.91 Million | 10.6 Million |
| Cash at end of period | 25.72 Million | 59.8 Million | 107.58 Million | 60.87 Million | 51.49 Million | 48.47 Million |
| Capital Expenditure | -133 Thousand | -147 Thousand | -61 Thousand | -7000.00 | -214 Thousand | -1.22 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -34.08 Million | -47.77 Million | 46.7 Million | 9.37 Million | 2.58 Million | 37.87 Million |
| Free Cash Flow | -43.74 Million | -66.44 Million | -84.37 Million | -78.75 Million | -65.05 Million | 12.52 Million |
| Breakdown | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.93 Million | -39.65 Million | -9.8 Million | -9.07 Million | -13.83 Million | -69.21 Million |
| Depreciation & Amortization | 65 Thousand | 255 Thousand | 62 Thousand | 64 Thousand | 64 Thousand | 65 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 936 Thousand | 4.03 Million | 939 Thousand | 975 Thousand | 1.18 Million | 2.34 Million |
| Change in working capital | -2.78 Million | -7.42 Million | 326 Thousand | -1.27 Million | -3.69 Million | 83 Thousand |
| Other non-cash items | 123 Thousand | -817 Thousand | 286 Thousand | -1.95 Million | 273 Thousand | 41.14 Million |
| Investing Cash Flow | -23 Thousand | -133 Thousand | - | -110 Thousand | - | -39 Thousand |
| Investments in PPE | -23 Thousand | -133 Thousand | - | -110 Thousand | - | -39 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4000.00 | 9.65 Million | 15 Thousand | 8.49 Million | 1.13 Million | 655 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.48 Million | 9.63 Million | 15 Thousand | 8.48 Million | 1.13 Million | 776 Thousand |
| Other Financing Activities | -8.48 Million | 16 Thousand | - | 12 Thousand | - | -121 Thousand |
| Accounts receivables | - | - | - | - | -127 Thousand | - |
| Accounts payables | -280 Thousand | -2.91 Million | 22 Thousand | -1.13 Million | -1.52 Million | 718 Thousand |
| Inventory | - | - | - | - | 127 Thousand | - |
| Other working capital | -2.5 Million | -4.5 Million | - | -140 Thousand | -2.16 Million | -635 Thousand |
| Cash at beginning of period | 34.33 Million | 59.8 Million | 42.05 Million | 44.93 Million | 59.8 Million | 84.76 Million |
| Cash at end of period | 25.72 Million | 25.72 Million | 34.33 Million | 42.05 Million | 44.93 Million | 59.8 Million |
| Capital Expenditure | -23 Thousand | -133 Thousand | - | -110 Thousand | - | -39 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.61 Million | -34.08 Million | -7.72 Million | -2.87 Million | -14.87 Million | -24.95 Million |
| Free Cash Flow | -8.62 Million | -43.74 Million | -7.73 Million | -11.37 Million | -16.01 Million | -25.61 Million |
JCH
2880
3463
HYDRO
AFX
2173